{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:28:35Z","timestamp":1789972115590,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.neuroscience.2011.12.011","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T03:23:40Z","timestamp":1323833020000},"page":"170-179","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-\u03b1-synuclein and the pesticide, rotenone"],"prefix":"10.1016","volume":"203","author":[{"given":"P.","family":"Mulcahy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"O'Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Paucard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kirik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuroscience.2011.12.011_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0306-4522(95)00112-V","article-title":"Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat","volume":"67","author":"Barneoud","year":"1995","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuroscience.2011.12.011_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2011.12.011_bib3","article-title":"Early diagnosis of Parkinson's disease","volume":"249","author":"Becker","year":"2002","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.neuroscience.2011.12.011_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"issue":"02","key":"10.1016\/j.neuroscience.2011.12.011_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2007-971168","article-title":"Neuroprotection in Parkinson's disease: an elusive goal","volume":"27","author":"Biglan","year":"2007","journal-title":"Semin Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2011.12.011_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(00)02915-2","article-title":"Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model","volume":"886","author":"Bjorklund","year":"2000","journal-title":"Brain Res"},{"issue":"11","key":"10.1016\/j.neuroscience.2011.12.011_bib7","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/tx049867r","article-title":"Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease","volume":"17","author":"Caboni","year":"2004","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.neuroscience.2011.12.011_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2007.05.022","article-title":"Cell systems and the toxic mechanism(s) of alpha-synuclein","volume":"209","author":"Cookson","year":"2008","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.neuroscience.2011.12.011_bib9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0005-2728(98)00029-2","article-title":"Inhibitors of NADH-ubiquinone reductase: an overview","volume":"1364","author":"Degli Esposti","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2011.12.011_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainresbull.2005.08.009","article-title":"The corridor task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum","volume":"68","author":"Dowd","year":"2005","journal-title":"Brain Res Bull"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbr.2006.01.013","article-title":"Further validation of the corridor task for assessing deficit and recovery in the hemi-parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism","volume":"169","author":"Fitzsimmons","year":"2006","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.neuroscience.2011.12.011_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.brainresbull.2008.08.018","article-title":"Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat","volume":"77","author":"Grealish","year":"2008","journal-title":"Brain Res Bull"},{"issue":"18","key":"10.1016\/j.neuroscience.2011.12.011_bib14","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","article-title":"Novel tools for production and purification of recombinant adenoassociated virus vectors","volume":"9","author":"Grimm","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.12.011_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","article-title":"Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"62","author":"Heikkila","year":"1985","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.12.011_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","article-title":"Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats","volume":"84","author":"Hoglinger","year":"2003","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neuroscience.2011.12.011_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2005.03493.x","article-title":"The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy","volume":"95","author":"Hoglinger","year":"2005","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neuroscience.2011.12.011_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncpneuro0491","article-title":"Why hasn't neuroprotection worked in Parkinson's disease?","volume":"3","author":"Kieburtz","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"issue":"5","key":"10.1016\/j.neuroscience.2011.12.011_bib19","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp Neurol"},{"issue":"7","key":"10.1016\/j.neuroscience.2011.12.011_bib21","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2011.12.011_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbr.2011.03.018","article-title":"Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note","volume":"222","author":"Klein","year":"2011","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neurobiolaging.2005.12.005","article-title":"Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression","volume":"28","author":"Lauwers","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.12.011_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"issue":"R1","key":"10.1016\/j.neuroscience.2011.12.011_bib25","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.neuroscience.2011.12.011_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mds.20120","article-title":"Recent failures of new potential symptomatic treatments for Parkinson's disease: causes and solutions","volume":"19","author":"Linazasoro","year":"2004","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.neuroscience.2011.12.011_bib27","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"Alpha synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.neuroscience.2011.12.011_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-008-0350-x","article-title":"Animal models of Parkinson's disease progression","volume":"115","author":"Meredith","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2011.12.011_bib29","article-title":"Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a New approach for an old neurotoxin","author":"Moreira","year":"2011","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2011.12.011_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2011.01.038","article-title":"Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone","volume":"181","author":"Mulcahy","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2011.12.011_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2010.08.070","article-title":"Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle","volume":"1360","author":"Norazit","year":"2010","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.neuroscience.2011.12.011_bib32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/mds.20243","article-title":"Levodopa in the treatment of Parkinson's disease: current controversies","volume":"19","author":"Olanow","year":"2004","journal-title":"Mov Disord"},{"issue":"5 Pt 2","key":"10.1016\/j.neuroscience.2011.12.011_bib33","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J Neurosci"},{"issue":"42","key":"10.1016\/j.neuroscience.2011.12.011_bib34","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.2149-10.2010","article-title":"Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition","volume":"30","author":"Paille","year":"2010","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1353-8020(01)00023-2","article-title":"Levodopa prolongs life expectancy and is non-toxic to substantia nigra","volume":"8","author":"Rajput","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vascn.2007.10.003","article-title":"The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments","volume":"57","author":"Ravenstijn","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"9423","key":"10.1016\/j.neuroscience.2011.12.011_bib37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.neuroscience.2011.12.011_bib38","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2005.04.051","article-title":"Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease","volume":"1049","author":"Saravanan","year":"2005","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.neuroscience.2011.12.011_bib40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2011.12.011_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pbb.2006.05.017","article-title":"Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine","volume":"84","author":"Sindhu","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2011.12.011_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2005.05.051","article-title":"Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion","volume":"1051","author":"Sindhu","year":"2005","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.neuroscience.2011.12.011_bib44","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra","volume":"100","author":"St Martin","year":"2007","journal-title":"J Neurochem"},{"issue":"1\u20133","key":"10.1016\/j.neuroscience.2011.12.011_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2010.03.019","article-title":"A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats","volume":"272","author":"Swarnkar","year":"2010","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.12.011_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2011.03.036","article-title":"Rotenone induced neurotoxicity in rat brain areas: a histopathological study","volume":"501","author":"Swarnkar","year":"2011","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.neuroscience.2011.12.011_bib47","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect"},{"issue":"12","key":"10.1016\/j.neuroscience.2011.12.011_bib48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.12.011_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02597-2","article-title":"Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease","volume":"500","author":"Uversky","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2011.12.011_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuroscience.2010.12.005","article-title":"Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat","volume":"175","author":"Walsh","year":"2011","journal-title":"Neuroscience"},{"issue":"Suppl 3","key":"10.1016\/j.neuroscience.2011.12.011_bib51","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","article-title":"Genetic and environmental factors in the cause of Parkinson's disease","volume":"53","author":"Warner","year":"2003","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neuroscience.2011.12.011_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/REVNEURO.2004.15.1.75","article-title":"The implementation of acute versus chronic animal models for treatment discovery in Parkinson's disease","volume":"15","author":"Willis","year":"2004","journal-title":"Rev Neurosci"},{"issue":"11","key":"10.1016\/j.neuroscience.2011.12.011_bib53","doi-asserted-by":"crossref","first-page":"e7878","DOI":"10.1371\/journal.pone.0007878","article-title":"Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease","volume":"4","author":"Xiong","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuroscience.2011.12.011_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.neuroscience.2011.12.011_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pbb.2011.09.002","article-title":"Acetyl-l-carnitine and alpha-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy","volume":"100","author":"Zaitone","year":"2011","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211013911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211013911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T21:04:01Z","timestamp":1713215041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452211013911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":55,"alternative-id":["S0306452211013911"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.12.011","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}